COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics présentera des données précliniques sur les propriétés ostéogéniques d’ALLOB dans la régénération osseuse à l’occasion de la 27e réunion annuelle de l’EORS (European Orthopaedic Research Society)
02/10/2019
Communiqué de presse Gosselies, Belgique, le 2 octobre 2019, 07h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE, éligible PEA-PME), société de biotechnologie spécialisée dans le développement de [...]
Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum
02/10/2019
Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA)[1] Novartis plans FDA submission for nr-axSpA, having [...]
Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference
02/10/2019
Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference Study highlights potential benefit in rare pediatric orthopedic [...]
BriaCell Therapeutics Corp. to Clarify Record Date
02/10/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
NextCure to Present Clinical Data from NC318 Phase 1/2 Clinical Trial at 34th Annual Meeting of SITC
02/10/2019
BELTSVILLE, Md., Oct. 01, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]
Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting
02/10/2019
CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
RavenQuest BioMed to Hold Third Quarter Conference Call
01/10/2019
VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”), one of Canada’s most innovative cannabis producers, [...]
Predictive Oncology Inc. Announces Proposed Public Offering of Common Stock
01/10/2019
MINNEAPOLIS, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced a proposed public offering of its common stock. The offering is subject to market [...]
ContraFect to Host Development Update Call and Webcast on October 2, 2019
01/10/2019
YONKERS, N.Y., Oct. 01, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and [...]
Sonoma Pharmaceuticals Announces Management Changes
01/10/2019
Agreement with CEO and Interim CFO Bubba Sandford ends Amy Trombly Appointed as Interim CEO John Dal Poggetto Appointed as New CFO PETALUMA, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
01/10/2019
Lakewood, Colo., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]
Retrophin Announces Appointment of Peter Heerma as Chief Commercial Officer
01/10/2019
SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Peter Heerma as chief commercial officer, effective immediately. In this newly created position, Mr. Heerma [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/10/2019
BOSTON, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
Sanofi : Availability of the Pre-quarterly Results Communication
01/10/2019
Availability of the pre-quarterly results communication Paris, France – October 1, 2019 – Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company' [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
01/10/2019
Mise en ligne du document «Pre-quarterly Results Communication » Paris - Le 1 er Octobre 2019 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Pre- [...]
Teligent Announces Strategic Review
01/10/2019
BUENA, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Teligent Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has retained SVB Leerink as its financial advisor to [...]
JSC Olainfarm publishes revised Corporate Governance Report
01/10/2019
JSC Olainfarm published annual Corporate Governance Report for 2018 on April 30, 2019. At the beginning of April significant changes occurred in the composition of Management Board and certain events of 2018 were not [...]
The Pennant Group, Inc. Announces Completion of Spin-off from The Ensign Group, Inc.
01/10/2019
EAGLE, Idaho, Oct. 01, 2019 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
OnMed Announces Strategic Alliance with athenahealth Inc. to Strengthen Digital Security in Telemedicine
01/10/2019
First telemedicine station to diagnose patients and dispense prescription medications announces a strategic alliance with athenahealth, Inc. to secure medical records CLEARWATER, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- [...]

Pages